An unbiased genome-wide Mycobacterium tuberculosis gene expression approach to discover antigens targeted by human T cells expressed during pulmonary infection

Journal of Immunology

Volumn 190, Issue 4, 2013, Pages 1659-1671

  Commandeur, Susanna ^a   Van Meijgaarden, Krista E ^a   Prins, Corine ^a   Pichugin, Alexander V ^b,e   Dijkman, Karin ^a   Van Den Eeden, Susan J F ^a   Friggen, Annemieke H ^a   Franken, Kees L M C ^a   Dolganov, Gregory ^c   Kramnik, Igor ^b,f   Schoolnik, Gary K ^c   Oftung, Fredrik ^d   Korsvold, Gro Ellen ^d   Geluk, Annemieke ^a   Ottenhoff, Tom H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; PROTEIN RV0079; PROTEIN RV1363C; PROTEIN RV2225; PROTEIN RV2380C; PROTEIN RV2435C; PROTEIN RV2465C; PROTEIN RV2737C; PROTEIN RV2828C; PROTEIN RV2982C; PROTEIN RV3515C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BCG VACCINATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FAD19 GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE LOCUS; GENETIC IDENTIFICATION; GENETIC SELECTION; GENOME ANALYSIS; GRANULOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; INFECTION SENSITIVITY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MBTE GENE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; NONHUMAN; PRIORITY JOURNAL; RBFA GENE; RECA GENE; RIMI GENE; RV0079 GENE; RV1284 GENE; RV2034 GENE; RV2324 GENE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; T LYMPHOCYTE; TUBERCULIN TEST;

ANIMALS; ANTIGENS, BACTERIAL; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, BACTERIAL; GENE TARGETING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY;

EID: 84873548317     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201593     Document Type: Article

References (70)

1. World Health Organization. 2011. The Global Plan to Stop TB 2011-2015. Available at: http://www.stoptb.org/assets/documents/global/plan/TB- GlobalPlanToStopTB2011-2015.pdf
2. Trunz, B. B., P. Fine, and C. Dye. 2006. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367: 1173-1180.
3. Fine, P. E. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346: 1339-1345.
4. Hesseling, A. C., B. J. Marais, R. P. Gie, H. S. Schaaf, P. E. Fine, P. Godfrey-Faussett, and N. Beyers. 2007. The risk of disseminated bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 25: 14-18.
5. Ottenhoff, T. H., F. A. Verreck, E. G. Lichtenauer-Kaligis, M. A. Hoeve, O. Sanal, and J. T. van Dissel. 2002. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat. Genet. 32: 97-105.
6. van de Vosse, E., M. A. Hoeve, and T. H. Ottenhoff. 2004. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect. Dis. 4: 739-749.
7. Voskuil, M. I., D. Schnappinger, K. C. Visconti, M. I. Harrell, G. M. Dolganov, D. R. Sherman, and G. K. Schoolnik. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198: 705-713.
8. Schnappinger, D., S. Ehrt, M. I. Voskuil, Y. Liu, J. A. Mangan, I. M. Monahan, G. Dolganov, B. Efron, P. D. Butcher, C. Nathan, and G. K. Schoolnik. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198: 693-704.
9. Leyten, E. M., M. Y. Lin, K. L. Franken, A. H. Friggen, C. Prins, K. E. van Meijgaarden, M. I. Voskuil, K. Weldingh, P. Andersen, G. K. Schoolnik, et al. 2006. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect. 8: 2052-2060.
10. Roupie, V., M. Romano, L. Zhang, H. Korf, M. Y. Lin, K. L. Franken, T. H. Ottenhoff, M. R. Klein, and K. Huygen. 2007. Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNAvaccinated and tuberculosis-infected mice. Infect. Immun. 75: 941-949.
11. Schuck, S. D., H. Mueller, F. Kunitz, A. Neher, H. Hoffmann, K. L. Franken, D. Repsilber, T. H. Ottenhoff, S. H. Kaufmann, and M. Jacobsen. 2009. Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection. PLoS ONE 4: e5590.
12. Black, G. F., B. A. Thiel, M. O. Ota, S. K. Parida, R. Adegbola, W. H. Boom, H. M. Dockrell, K. L. Franken, A. H. Friggen, P. C. Hill, et al; GCGH Biomarkers for TB Consortium. 2009. Immunogenicity of novel DosR regulonencoded candidate antigens of Mycobacterium tuberculosis in three highburden populations in Africa. Clin. Vaccine Immunol. 16: 1203-1212.
13. Goletti, D., O. Butera, V. Vanini, F. N. Lauria, C. Lange, K. L. Franken, C. Angeletti, T. H. Ottenhoff, and E. Girardi. 2010. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur. Respir. J. 36: 135-142.
14. Betts, J. C., P. T. Lukey, L. C. Robb, R. A. McAdam, and K. Duncan. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43: 717-731.
15. Aagaard, C., T. Hoang, J. Dietrich, P. J. Cardona, A. Izzo, G. Dolganov, G. K. Schoolnik, J. P. Cassidy, R. Billeskov, and P. Andersen. 2011. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat. Med. 17: 189-194.
16. Lin, P. L., J. Dietrich, E. Tan, R. M. Abalos, J. Burgos, C. Bigbee, M. Bigbee, L. Milk, H. P. Gideon, M. Rodgers, et al. 2012. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J. Clin. Invest. 122: 303-314.
17. Rustad, T. R., M. I. Harrell, R. Liao, and D. R. Sherman. 2008. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One 3: e1502.
18. Gideon, H. P., K. A. Wilkinson, T. R. Rustad, T. Oni, H. Guio, R. A. Kozak, D. R. Sherman, G. Meintjes, M. A. Behr, H. M. Vordermeier, et al. 2010. Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines. PLoS Pathog. 6: e1001237.
19. Cappelli, G., E. Volpe, M. Grassi, B. Liseo, V. Colizzi, and F. Mariani. 2006. Profiling of Mycobacterium tuberculosis gene expression during human macrophage infection: upregulation of the alternative sigma factor G, a group of transcriptional regulators, and proteins with unknown function. Res. Microbiol. 157: 445-455.
20. Talaat, A. M., R. Lyons, S. T. Howard, and S. A. Johnston. 2004. The temporal expression profile of Mycobacterium tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 101: 4602-4607.
21. Karakousis, P. C., T. Yoshimatsu, G. Lamichhane, S. C. Woolwine, E. L. Nuermberger, J. Grosset, and W. R. Bishai. 2004. Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. J. Exp. Med. 200: 647-657.
22. Young, D. 2009. Animal models of tuberculosis. Eur. J. Immunol. 39: 2011-2014.
23. Pichugin, A. V., B. S. Yan, A. Sloutsky, L. Kobzik, and I. Kramnik. 2009. Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts. Am. J. Pathol. 174: 2190-2201.
24. Pan, H., B. S. Yan, M. Rojas, Y. V. Shebzukhov, H. Zhou, L. Kobzik, D. E. Higgins, M. J. Daly, B. R. Bloom, and I. Kramnik. 2005. Ipr1 gene mediates innate immunity to tuberculosis. Nature 434: 767-772.
25. Kramnik, I. 2008. Genetic dissection of host resistance to Mycobacterium tuberculosis: the sst1 locus and the Ipr1 gene. Curr. Top. Microbiol. Immunol. 321: 123-148.
26. Grötzinger, T., K. Jensen, and H. Will. 1996. The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-g activation site and an imperfect IFNstimulated response element which mediate type I IFN inducibility. J. Biol. Chem. 271: 25253-25260.
27. Kadereit, S., D. R. Gewert, J. Galabru, A. G. Hovanessian, and E. F. Meurs. 1993. Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins. J. Biol. Chem. 268: 24432-24441.
28. Bloch, D. B., A. Nakajima, T. Gulick, J. D. Chiche, D. Orth, S. M. de La Monte, and K. D. Bloch. 2000. Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol. Cell. Biol. 20: 6138-6146.
29. Tosh, K., S. J. Campbell, K. Fielding, J. Sillah, B. Bah, P. Gustafson, K. Manneh, I. Lisse, G. Sirugo, S. Bennett, et al. 2006. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc. Natl. Acad. Sci. USA 103: 10364-10368.
30. Thye, T., E. N. Browne, M. A. Chinbuah, J. Gyapong, I. Osei, E. Owusu-Dabo, S. Niemann, S. Rüsch-Gerdes, R. D. Horstmann, and C. G. Meyer. 2006. No associations of human pulmonary tuberculosis with Sp110 variants. J. Med. Genet. 43: e32.
31. Szeszko, J. S., B. Healy, H. Stevens, Y. Balabanova, F. Drobniewski, J. A. Todd, and S. Nejentsev. 2007. Resequencing and association analysis of the SP110 gene in adult pulmonary tuberculosis. Hum. Genet. 121: 155-160.
32. Babb, C., E. H. Keet, P. D. van Helden, and E. G. Hoal. 2007. SP110 polymorphisms are not associated with pulmonary tuberculosis in a South African population. Hum. Genet. 121: 521-522.
33. Png, E., B. Alisjahbana, E. Sahiratmadja, S. Marzuki, R. Nelwan, I. Adnan, E. van de Vosse, M. Hibberd, R. van Crevel, T. H. Ottenhoff, and M. Seielstad. 2012. Polymorphisms in SP110 are not associated with pulmonary tuberculosis in Indonesians. Infect. Genet. Evol. 12: 1319-1323.
34. Ruiz-Larrañaga, O., J. M. Garrido, M. Iriondo, C. Manzano, E. Molina, I. Montes, P. Vazquez, A. P. Koets, V. P. Rutten, R. A. Juste, and A. Estonba. 2010. SP110 as a novel susceptibility gene for Mycobacterium avium subspecies paratuberculosis infection in cattle. J. Dairy Sci. 93: 5950-5958.
35. Yan, B. S., A. Kirby, Y. V. Shebzukhov, M. J. Daly, and I. Kramnik. 2006. Genetic architecture of tuberculosis resistance in a mouse model of infection. Genes Immun. 7: 201-210.
36. Yan, B. S., A. V. Pichugin, O. Jobe, L. Helming, E. B. Eruslanov, J. A. Gutiérrez-Pabello, M. Rojas, Y. V. Shebzukhov, L. Kobzik, and I. Kramnik. 2007. Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guérin vaccination are genetically controlled via a common sst1-mediated mechanism of innate immunity. J. Immunol. 179: 6919-6932.
37. +-Cl2 cotransporter (NKCC1) in asthmatic subjects. Genome Res. 11: 1473-1483.
38. Woodruff, P. G., H. A. Boushey, G. M. Dolganov, C. S. Barker, Y. H. Yang, S. Donnelly, A. Ellwanger, S. S. Sidhu, T. P. Dao-Pick, C. Pantoja, et al. 2007. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl. Acad. Sci. USA 104: 15858-15863.
39. Franken, K. L., H. S. Hiemstra, K. E. van Meijgaarden, Y. Subronto, J. den Hartigh, T. H. Ottenhoff, and J. W. Drijfhout. 2000. Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr. Purif. 18: 95-99.
40. Lin, M. Y., A. Geluk, S. G. Smith, A. L. Stewart, A. H. Friggen, K. L. Franken, M. J. Verduyn, K. E. van Meijgaarden, M. I. Voskuil, H. M. Dockrell, et al. 2007. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect. Immun. 75: 3523-3530.
41. Commandeur, S., K. E. van Meijgaarden, M. Y. Lin, K. L. Franken, A. H. Friggen, J. W. Drijfhout, F. Oftung, G. E. Korsvold, A. Geluk, and T. H. Ottenhoff. 2011. Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals. Clin. Vaccine Immunol. 18: 676-683.
42. + T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in longterm latently infected individuals. Eur. J. Immunol. 41: 2925-2936.
43. Fontán, P., V. Aris, S. Ghanny, P. Soteropoulos, and I. Smith. 2008. Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection. Infect. Immun. 76: 717-725.
44. Ma°len, H., F. S. Berven, K. E. Fladmark, and H. G. Wiker. 2007. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 7: 1702-1718.
45. Ma°len, H., S. Pathak, T. Søfteland, G. A. de Souza, and H. G. Wiker. 2010. Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv. BMC Microbiol. 10: 132.
46. de Souza, G. A., N. A. Leversen, H. Ma°len, and H. G. Wiker. 2011. Bacterial proteins with cleaved or uncleaved signal peptides of the general secretory pathway. J. Proteomics 75: 502-510.
47. Rosenkrands, I., A. King, K. Weldingh, M. Moniatte, E. Moertz, and P. Andersen. 2000. Towards the proteome of Mycobacterium tuberculosis. Electrophoresis 21: 3740-3756.
48. Mattow, J., U. E. Schaible, F. Schmidt, K. Hagens, F. Siejak, G. Brestrich, G. Haeselbarth, E. C. Müller, P. R. Jungblut, and S. H. Kaufmann. 2003. Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis 24: 3405-3420.
49. Wolfe, L. M., S. B. Mahaffey, N. A. Kruh, and K. M. Dobos. 2010. Proteomic definition of the cell wall of Mycobacterium tuberculosis. J. Proteome Res. 9: 5816-5826.
50. Kruh, N. A., J. Troudt, A. Izzo, J. Prenni, and K. M. Dobos. 2010. Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo. PLoS ONE 5: e13938.
51. Gu, S., J. Chen, K. M. Dobos, E. M. Bradbury, J. T. Belisle, and X. Chen. 2003. Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Mol. Cell. Proteomics 2: 1284-1296.
52. Mawuenyega, K. G., C. V. Forst, K. M. Dobos, J. T. Belisle, J. Chen, E. M. Bradbury, A. R. Bradbury, and X. Chen. 2005. Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Mol. Biol. Cell 16: 396-404.
53. Sassetti, C. M., D. H. Boyd, and E. J. Rubin. 2003. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48: 77-84.
54. Sassetti, C. M., and E. J. Rubin. 2003. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA 100: 12989-12994.
55. Lamichhane, G., M. Zignol, N. J. Blades, D. E. Geiman, A. Dougherty, J. Grosset, K. W. Broman, and W. R. Bishai. 2003. A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 100: 7213-7218.
56. Griffin, J. E., J. D. Gawronski, M. A. Dejesus, T. R. Ioerger, B. J. Akerley, and C. M. Sassetti. 2011. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog. 7: e1002251.
57. Dutta, N. K., S. Mehra, P. J. Didier, C. J. Roy, L. A. Doyle, X. Alvarez, M. Ratterree, N. A. Be, G. Lamichhane, S. K. Jain, et al. 2010. Genetic requirements for the survival of tubercle bacilli in primates. J. Infect. Dis. 201: 1743-1752.
58. + T cells specific for defined antigens according to CD154 expression. Nat. Med. 11: 1118-1124.
59. Ward, S. K., B. Abomoelak, S. A. Marcus, and A. M. Talaat. 2010. Transcriptional profiling of mycobacterium tuberculosis during infection: lessons learned. Front. Microbiol. 1: 121.
60. Rachman, H., M. Strong, U. Schaible, J. Schuchhardt, K. Hagens, H. Mollenkopf, D. Eisenberg, and S. H. Kaufmann. 2006. Mycobacterium tuberculosis gene expression profiling within the context of protein networks. Microbes Infect. 8: 747-757.
61. Ramakrishnan, L., N. A. Federspiel, and S. Falkow. 2000. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288: 1436-1439.
62. Chan, K., T. Knaak, L. Satkamp, O. Humbert, S. Falkow, and L. Ramakrishnan. 2002. Complex pattern of Mycobacterium marinum gene expression during longterm granulomatous infection. Proc. Natl. Acad. Sci. USA 99: 3920-3925.
63. McKinney, J. D., K. Hönerzu-Bentrup, E. J. Muñoz-Elías, A. Miczak, B. Chen, W. T. Chan, D. Swenson, J. C. Sacchettini, W. R. Jacobs, Jr., and D. G. Russell. 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406: 735-738.
64. Muñoz-Elías, E. J., and J. D. McKinney. 2005. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11: 638-644.
65. Harriff, M. J., G. E. Purdy, and D. M. Lewinsohn. 2012. Escape from the phagosome: the explanation for MHC-I processing of mycobacterial antigens? Front. Immunol. 3: 40.
66. Mogues, T., M. E. Goodrich, L. Ryan, R. LaCourse, and R. J. North. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193: 271-280.
67. + effector T cells in Mycobacterium tuberculosis infection. J. Immunol. 189: 2530-2536.
68. Chegou, N. N., G. F. Black, A. G. Loxton, K. Stanley, P. N. Essone, M. R. Klein, S. K. Parida, S. H. Kaufmann, T. M. Doherty, A. H. Friggen, et al. 2012. Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infect. Dis. 12: 10.
69. Jones, G. J., C. Pirson, H. P. Gideon, K. A. Wilkinson, D. R. Sherman, R. J. Wilkinson, R. G. Hewinson, and H. M. Vordermeier. 2011. Immune responses to the enduring hypoxic response antigen Rv0188 are preferentially detected in Mycobacterium bovis infected cattle with low pathology. PLoS ONE 6: e21371.
70. Ottenhoff, T. H., and S. H. Kaufmann. 2012. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 8: e1002607.